1.
Popat R, Uttervall K, Kortüm K, Magen H, Hansson M, Shragai T, Terpos E, Hansen CT, Manier S, Gregersen H, Ottestad Ø.M., Touzeau C, Hatjiharissi E, Farmer S, Katodritou E, Spanoudakis E, Vase M, Liberatore C, Papathanasiou M, Angelopoulou M, Clavero E, Kittus R, Smirnov P, Hu P, Santra D, Albrecht C, Rubio-Azpeitia E, Perrot A. P41 | FIRST RESULTS OF REALiTEC-2: SECOND COHORT OF REALiTEC, AN INTERNATIONAL OBSERVATIONAL RETROSPECTIVE STUDY OF TECLISTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN ROUTINE CLINICAL PRACTICE. Haematologica 2026; 111(s2); https://doi.org/10.3324/haematol.2026.s2.14038.